Amalgamated Bank’s Apellis Pharmaceuticals APLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$140K Buy
8,111
+866
+12% +$14.9K ﹤0.01% 1639
2025
Q1
$158K Buy
7,245
+291
+4% +$6.35K ﹤0.01% 1587
2024
Q4
$222K Sell
6,954
-41
-0.6% -$1.31K ﹤0.01% 1549
2024
Q3
$202K Hold
6,995
﹤0.01% 1580
2024
Q2
$268K Buy
6,995
+359
+5% +$13.8K ﹤0.01% 1501
2024
Q1
$390K Sell
6,636
-13,821
-68% -$812K ﹤0.01% 1404
2023
Q4
$1.23M Sell
20,457
-1,728
-8% -$103K 0.01% 1083
2023
Q3
$844K Buy
22,185
+763
+4% +$29K 0.01% 1183
2023
Q2
$1.95M Buy
21,422
+8,128
+61% +$741K 0.02% 897
2023
Q1
$877K Sell
13,294
-2,109
-14% -$139K 0.01% 1161
2022
Q4
$796K Buy
15,403
+231
+2% +$11.9K 0.01% 1243
2022
Q3
$1.04M Buy
15,172
+772
+5% +$52.7K 0.01% 1093
2022
Q2
$651K Buy
14,400
+1,936
+16% +$87.5K 0.01% 1337
2022
Q1
$633K Sell
12,464
-87
-0.7% -$4.42K ﹤0.01% 1449
2021
Q4
$593K Buy
12,551
+997
+9% +$47.1K ﹤0.01% 1498
2021
Q3
$381K Sell
11,554
-711
-6% -$23.4K ﹤0.01% 1723
2021
Q2
$775K Buy
12,265
+3,715
+43% +$235K 0.01% 1409
2021
Q1
$367K Sell
8,550
-833
-9% -$35.8K 0.01% 1146
2020
Q4
$537K Buy
9,383
+51
+0.5% +$2.92K 0.02% 925
2020
Q3
$282K Sell
9,332
-282
-3% -$8.52K 0.01% 1139
2020
Q2
$314K Buy
9,614
+127
+1% +$4.15K 0.01% 1083
2020
Q1
$254K Buy
9,487
+748
+9% +$20K 0.01% 1228
2019
Q4
$268K Buy
8,739
+162
+2% +$4.97K ﹤0.01% 1475
2019
Q3
$207K Sell
8,577
-80
-0.9% -$1.93K ﹤0.01% 1527
2019
Q2
$219K Buy
+8,657
New +$219K 0.01% 1533